Surrozen Funding & Investors
Surrozen Inc produces and distributes pharmaceutical products. The Company develops pathway that drive tissue regeneration addressing a variety of critical unmet medical needs. Surrozen operates in the United States.
surrozen.comTotal Amount Raised: $253,000,000
Surrozen Funding Rounds
Post Ipo Equity
$120,000,000
Post Ipo Equity Investors
Consonance CapitalThe Column GroupSeries C
$50,000,000
Series C Investors
Euclidean CapitalThe Column GroupHorizons VenturesSeries B
$50,000,000
Series B Investors
Hartford HealthCare EndowmentNS InvestmentThe Column GroupHorizons VenturesSeries A
$33,000,000
Series A Investors
The Column Group
Funding info provided by Diffbot.